• <table id="kmmkk"><li id="kmmkk"></li></table>
  • <table id="kmmkk"><td id="kmmkk"></td></table>
  • <table id="kmmkk"></table>
  • <table id="kmmkk"><td id="kmmkk"></td></table>
  • <xmp id="kmmkk"><td id="kmmkk"></td>
    <table id="kmmkk"><td id="kmmkk"></td></table>
  • <table id="kmmkk"><td id="kmmkk"></td></table>
  • <table id="kmmkk"><li id="kmmkk"></li></table>
  • <table id="kmmkk"></table>
  • <table id="kmmkk"><li id="kmmkk"></li></table>
  • API industry waking up

    Publish Time:2011-12-19

     

        Experience the stagnation of the past two years, after the active drug industry restore sight. April 21 to 23, and more than 1000 drug production enterprise in chengdu 66th API. API enterprise the crowds and a continuous stream of booths from foreign customers to visit, let people really believe that the domestic API industry has been out of the economic crisis in the shadows, restored the previous boom.

        Related statistical data show that in 2010, China's import and export turn the chemical raw materials since 2008 games, chemical raw materials of imports to 3.3 billion us dollars, up by 10%; Export total 13.78 billion us dollars, up 22.66%. In 2010, China's exports exceeded $100 million for the API of enterprise has reached to 26, an increase of 30%.

        In the import and export growth last year API good circumstances, to meet domestic exhibitors and overseas customer demand, the API will also AD hoc "export and OEM zone".

        And reporters in the active pharmaceutical ingredients (apis), found that antibiotics, vitamins, amino acids such as firmly in China before 3 exports API occupy the best medicines at the event still popular, and some features for API more and more attention.

        Emerging market contribution outstanding

        China's apis are out of the shadow of the economic crisis, global generic-drugs market demand expansion and industrial transfer in China, further expand the international market apis provides opportunities and space. In 2010, China's total import and export commodities of drugs for 28.2 billion us dollars, up 22%. One drug exports totaled $17.48 billion, chemical raw materials export volume was 13.78 billion us dollars, up 22.66%, chemical raw materials exports of all drugs accounted for 79% of total export amount.

        "For nearly 12 years through our country exports of apis, tracking data indicate the export of active pharmaceutical ingredients (apis) after the 2008, 2009 years of stagnation, in 2010 after rebounded, active pharmaceutical ingredients (apis) out of the economic crisis export has shadows. Apis by exports price fluctuation, environmental protection the transformation, the international trade of change and intellectual property rights and so on many factors influence is year after year improvement. But in a few years, the industry will face common API energy prices of raw materials and cost of the ascension, recently a year or two prices is big trend apis." The expert inside course of study says.

        But the relevant statistics show that in China last year in the developed countries and the API exports from developing countries generally rise, occupy the top five countries were the us, India, Germany, Japan, the Netherlands, developed countries still occupy a major position, India has become China's second largest export market of apis, at $2.276 billion, China API become an important source of Indian drugs.

        In addition, our country to other countries, API gold ingot Middle East and South America and other emerging market countries export growth more rapid, Brazil, South Korea, Thailand, Indonesia, Russia, Mexico, nearly 10 emerging countries in succession in China's market API's total exports top 20, emerging trade area become most potential regional market.

        Along with the increase of the international market development apis, in 2010, of our country export API enterprise exports more than $100 million to 26 of the house in 2009, the number of less than 20 home, including shenzhen sea pury (27.14, 0.38,-1.38%) pharmaceutical in $548 million in exports first. But rough machining, of the basic API has gradually withdraw from Europe, enterprise in Europe to high-end market is the only road.

        The export structure nutrition subtle

        Specific to breed character, export commodities, antibiotics, vitamins, amino acid, organic acids such as biochemical class is still the main apis export composition. Although large product low value-added export dominant position didn't happen too big change, but because of its development space has a certain limitation, penicillin, vitamin C and other apis export prices or decline, the other a great variety of glutamate the rate of growth of into the relatively calm period.

        In the last year, with the amount of drug intermediates single variety of more than us $100 million and only varieties, heparin sodium with $1.2 billion of the total amount of export first, he's set, potassium sorbet, erythromycin thiocyanate, doxycycline, azithromycin, and other varieties of exports exceeded $100 million for the first time. The large ring lactone class, sweetener, antivirus, and spices drugs gradually revealed strong API, and traditional strengths of penicillin, strain, the breed such as AnNaiJin were in continue to sink down.

        In the next few years, the large ring lactone series, pei south series, sweetener series apis will become a high boom varieties. At present macrolides in the number of the total tonnage exported close to 4000 tons, according to estimates, domestic medicinal big ring lactone class should be around 8000 tons, and these varieties of good market trend will also draw active investors.

        Some experts think the, the export structure of the API have quietly nutrition, the mass of the basic API, even is easy to cause pollution or is of gas-guzzling products will not to bring in, and some small scale, involve less competitive enterprise, may be in the domestic market is not big, but international markets are still have space is to be inspected the varieties.

        "Green, low carbon, environmental protection is all domestic production enterprises apis must face up to the problem." China's chemical (5.82, 0.09, 1.52% of the pharmaceutical industry association, deputy director of the expert committee ShenXianJi points out, "in the industry in the process of regional structure adjustment, should keep a chemical raw materials to environment bearing capacity of the weak area move. Future production enterprise in the environmental protection of apis into will no doubt increase on, and they also for its created and international counterparts more fair competition starting point, the only way of the API, China export will be more competitive."

    亚洲成在人线天堂网站
  • <table id="kmmkk"><li id="kmmkk"></li></table>
  • <table id="kmmkk"><td id="kmmkk"></td></table>
  • <table id="kmmkk"></table>
  • <table id="kmmkk"><td id="kmmkk"></td></table>
  • <xmp id="kmmkk"><td id="kmmkk"></td>
    <table id="kmmkk"><td id="kmmkk"></td></table>
  • <table id="kmmkk"><td id="kmmkk"></td></table>
  • <table id="kmmkk"><li id="kmmkk"></li></table>
  • <table id="kmmkk"></table>
  • <table id="kmmkk"><li id="kmmkk"></li></table>